Furthermore, physicians could consider alternatives to transfusion and implement strategies that include pharmacological correction of anemia using erythropoietin (although expensive), oral or intravenous iron (in selected patients), and use of antifibrinolytics (e.g. epsilon aminocaproic acid) to prevent bleeding in patients with thrombocytopenia22–24. The gene discussed is EPO; the disease is anemia.